Shivani Kapadia

Adjunctive Brexpiprazole in Patients With Major Depressive Disorder Including in a Subgroup With Energy/Concentration Symptoms: Time to Efficacy Onset

This post hoc pooled analysis of three randomized, fixed-dose, 6-week studies explored time to efficacy onset of adjunctive brexpiprazole 2–3 mg/day in patients with major depressive diso...

Shivani Kapadia ;

10/26/2023

Adjunctive Brexpiprazole in Patients With Major Depressive Disorder Who Had One Prior Inadequate Antidepressant Including in a Subgroup With Energy/Concentration Symptoms

This post hoc pooled analysis of three randomized, fixed-dose, 6-week studies explored the efficacy of adjunctive brexpiprazole 2–3 mg/day in patients with major depressive disorder who h...

Shivani Kapadia ;

10/26/2023